SYSTEMS IMMUNOPEPTIDOMICS
Mass Spectrometry-based Immunopeptidomics
& Systems Immunology
PARADIGM SHIFTING SCIENCE
The field of immunopeptidomics will become as transformative as cancer genomics and will revolutionize cancer immunotherapy to improve patient care worldwide.
​
The Caron Lab moved to Yale University in 2024 to achieve this goal!
PASSION CAN CURE ANYTHING!
WHY WE DO IT
Immunopeptidomics is an emerging multidisciplinary science and has impact in various research fields of immunology:
-
Response to infection
-
Inflammation
-
Cancer immunology
-
Microbiome and immunology of barrier tissues
-
Neuroimmunology
-
Autoimmunity, allergy and transplantation
-
Leukocyte development and differentiation
Acknowledgement: David S. Goodsell, RCSB Protein Data Bank. doi: 10.2210/rcsb_pdb/goodsell-gallery-022
WHAT WE DO
-
Develop next-generation immunopeptidomics technologies
-
Develop a systems immunopeptidomics framework to challenge the current T-cell activation paradigm
-
Collaborate with clinical investigators and researchers in the field of autoimmunity, infectious diseases and cancer
